About Us

text-image

About Illumina Ventures

We are the premier genomics and precision health venture firm supporting early-stage companies to improve human health.

text-columns

WHAT SETS US APART

Independently managed, we bring depth of knowledge, decades of domain expertise, strong operating experience, and a strategic relationship with Illumina (NASDAQ: ILMN). This enables us to identify and build companies that will transform healthcare and our world. We operate as true partners to entrepreneurs developing breakthrough science and technology into market-leading companies. Through Illumina Ventures Labs, we accelerate value creation for early-stage genomics start-ups via access to capital, sequencing, mentorship, and fully equipped genomics lab capabilities.

gallery-cards

Investment Strategy

We invest across the ecosystem:

Life Sciences Tools

Life Sciences Tools

  • Single cell analysis
  • Spatial biology
  • Multi-omic profiling
  • Synthetic biology
  • Molecular characterization

Diagnostics

Diagnostics

  • Infectious disease diagnostics
  • Cell free DNA, RNA and protein analysis
  • Pediatric genomics
  • Point of care solutions

Therapeutics

Therapeutics

  • Cell and gene therapies
  • Gene editing platforms
  • AI-enabled drug discovery
  • Nonviral delivery systems
  • Therapeutic protein libraries

Digital Health

Digital Health

  • Virtual care delivery
  • Patient engagement and care navigation
  • AI/ML enabled clinical care innovation

Sustainability

Sustainability

  • Agricultural biotechnology
  • Biomanufacturing
  • Bioremediation
  • Bioexploration